ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 366

Traditional Cardiac Risk Factors Predict Significant Coronary Plaque Burden In Asymptomatic Patients With Rheumatoid Arthritis

George A. Karpouzas1, Jennifer Malpeso2, Tae-Young Choi2, Youngju Pak3 and Matthew Budoff2, 1Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, 2Cardiology, Harbor-UCLA Medical Center, Torrance, CA, 3Biostatistics, Harbor-UCLA Medical Center, Torrance, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Computed tomography (CT), heart disease and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects I: Comorbidities in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Computed tomography angiography (CTA) provides prognostic information in patients with suspected but unknown coronary artery disease (CAD); subjects without plaque had no incident major cardiovascular events (MACE) at 52 months. In those with obstructive plaque (>50% stenosis) or significant plaque burden [segment involvement score (SIS)>5, or segment stenosis score (SSS)>5] incident MACE was noted in 69%, 75%, and 80% respectively at 52 months. We evaluated the contributions of demographic, traditional cardiac risk factors (CRF) and rheumatoid arthritis (RA)- associated variables on the risk of having obstructive plaque, SIS>5, or SSS>5 in 150 subjects with RA and no symptoms or diagnosis of CAD compared to 150 age and gender-matched controls.

Methods: Patients and controls underwent CTA; qualitative and quantitative plaque evaluation was carried out using a standard 15- coronary segment American Heart Association Model. Subjects with either obstructive plaque, or SIS>5, or SSS>5 where considered high-risk; the remainder were considered low-risk. Chi-square or Fisher’s exact tests evaluated the associations between binary variables and high-risk outcomes while simple logistic regression model was used for continuous variables. The Breslow-Day test assessed homogeneity of OR between two groups.

Results: A higher proportion of RA subjects were classified in the high-risk group: 23 (15.3%) vs. 8 (5.3%) in controls, OR (95%CI)=3.2 (1.4-7.4), p=0.004. Age was a significant determinant of high risk for the entire cohort (n=300) [OR=1.08 (1.04-1.13), p=0.0004], as well as for the RA group [OR=1.09 (1.04-1.15), p=0.001], but not the controls [OR=1.06 (0.98-1.15), p=0.14]. In RA patients, age>55 years was the best predictor of high-risk outcome, followed by male gender, diabetes, and hypertension (table 1); none of the RA-associated parameters predicted such outcome. No demographic or CRF predicted high-risk outcomes in controls. Significant interactions were observed between male gender and hypertension for high-risk outcomes in RA patients (p=0.024, and p=0.04 respectively).

Conclusion: Demographic and traditional CRF such as age, male gender, diabetes, and hypertension in decreasing significance predict obstructive or high burden coronary plaque by CTA in patients with RA and no symptoms or diagnosis of CAD. Male gender and hypertension differentially predict such outcomes in RA compared to controls.

Table 1. Outcome= presence of obstructive plaque (>50% stenosis), or SSS>5, or SIS>5 (High-risk) vs. not (low-risk)

RA- univariate

Controls-univariate

RA vs. controls-differences in OR (Breslow-Day test)

parameters

OR

p

OR

p

p

Age>(55)

5.93 (2.1-17)

0.0003

2.27 (0.5-9.9)

0.3

0.29

Male

5.62 (1.9-16.2)

0.002

N/A*

0.6

0.026

HTN

2.9 (1.1-7.5)

0.02

0.4 (0.09-2.3)

0.47

0.04

DM

4.2 (1.56-11.1)

0.005

1.56 (0.3-8.2)

0.6

0.3

Dyslipidemia

0.4 (0.09-1.9)

0.37

1.3 (0.3-5.5)

0.7

0.25

smoking

1.0 (0.2-4.86)

1

N/A*

0.6

0.27

FHx

1.1 (0.12-9.95)

1

0.4 (0.1-1.9)

0.3

0.48

RA>5 years

2.35 (0.75-7.3)

0.14

–

–

–

RF (+) & a-CCP (+)

1 (0.2-4.8)

1

–

–

–

DAS28-3v>3.2

1.37 (0.56-3.3)

0.5

–

–

–

Erosions

1.55 (0.57-4.2)

0.47

–

–

–

JRS

1.43 (0.37-5.5)

0.7

–

–

–

*N/A: OR not applicable due to presence of 0 cell value


Disclosure:

G. A. Karpouzas,
None;

J. Malpeso,
None;

T. Y. Choi,
None;

Y. Pak,
None;

M. Budoff,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/traditional-cardiac-risk-factors-predict-significant-coronary-plaque-burden-in-asymptomatic-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology